Pharmafile Logo

Glaucoma in perspective

Bristol-Myers Squibb (BMS) building

BMS claims 80% market share for Opdivo in US

New indications and label updates boost the cancer immunotherapy’s market position

- PMLiVE

AbbVie adds to cancer portfolio with $9.8bn Stemcentrx deal

Continues to build its oncology business to lessen its reliance on Humira

Is it possible to change behaviour virtually?

Changing behaviour requires a combination of science and art. As technology evolves, so does the breadth of mechanisms (the ‘art’) through which we can deliver science-based, behaviour-change interventions. As the...

- PMLiVE

Quintiles promotes Robert Taylor

He becomes head of Europe, commercial solutions

- PMLiVE

Merck appoints ex-Pfizer exec as global head of oncology

Maya Martinez-Davis succeeds Andrew Schiermeier in the role

Incisive Health Bill Morgan Sarah Winstone Mike Birtwistle

Incisive Health goes international with Brussels office

Follows work for the likes of AbbVie, EFPIA and the Global Lung Cancer Coalition

Porterhouse Medical Brian Parsons Jon Hallows

Queen’s Awards for Enterprise for STEM and Porterhouse

International trade honours recognise the two firms' rapid overseas expansion

Sanofi reception

Sanofi makes $9.3bn unsolicited bid for Medivation

Hopes to boost oncology business with fast-growing prostate cancer drug Xtandi

- PMLiVE

Respiratory return helps GSK to solid first quarter

Seretide decline offset by gains for new-generation products Anoro, Breo and Nucala

- PMLiVE

Managing real world data governance

An aspirational framework to make the most of data and its role in improving patient care

Mannatech creates global scientific advisory board

Appoints Dr Steve Nugent as chairman of the board

- PMLiVE

Blue Latitude Health bolsters team with seven new hires

Expands the agency’s creative, consultancy and accounts divisions

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links